These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2868365)

  • 1. HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection.
    Follett EA; McIntyre A; O'Donnell B; Clements GB; Desselberger U
    Lancet; 1986 Feb; 1(8478):446-7. PubMed ID: 2868365
    [No Abstract]   [Full Text] [Related]  

  • 2. HTLV-III antibody in Edinburgh drug addicts.
    Peutherer JF; Edmond E; Simmonds P; Dickson JD; Bath GE
    Lancet; 1985 Nov; 2(8464):1129-30. PubMed ID: 2865601
    [No Abstract]   [Full Text] [Related]  

  • 3. HTLV-III antibodies in an Edinburgh clinic.
    Brettle RP; Davidson J; Davidson SJ; Gray JM; Inglis JM; Conn JS; Bath GE; Gillon J; McClelland DB
    Lancet; 1986 May; 1(8489):1099. PubMed ID: 2871367
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive.
    Novick DM; Farci P; Croxson TS; Taylor MB; Schneebaum CW; Lai ME; Bach N; Senie RT; Gelb AM; Kreek MJ
    J Infect Dis; 1988 Oct; 158(4):795-803. PubMed ID: 3171227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
    Pont J; Neuwald C; Kunz C; Werdenich W
    Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a North-German drug clinic.
    Paschelke G; Altvater-Kremer G; Meyer WD; Kremer H
    Klin Wochenschr; 1987 Jan; 65(1):22-6. PubMed ID: 3470556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of serum antibody to human immunodeficiency virus among hospitalized intravenous drug abusers in a low-risk geographic area.
    Wendt D; Sadowski L; Markowitz N; Saravolatz L
    J Infect Dis; 1987 Jan; 155(1):151-2. PubMed ID: 3466962
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of infections caused by AIDS and hepatitis B viruses in jailed people.
    Crovari P; Cassini U; Infante D; Guano F; Icardi GC; Auteri G; Di Ponzio A; Cuneo Crovari P
    Boll Ist Sieroter Milan; 1985; 64(5):367-70. PubMed ID: 3004543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HTLV-III, virus hepatitis B and CMV in Chilean homosexuals].
    Velasco M; Sepúlveda C
    Rev Med Chil; 1985 Jun; 113(6):587-9. PubMed ID: 3010422
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 11. Human immunodeficiency virus and drug misuse: the Edinburgh experience.
    Brettle RP; Bisset K; Burns S; Davidson J; Davidson SJ; Gray JM; Inglis JM; Lees JS; Mok J
    Br Med J (Clin Res Ed); 1987 Aug; 295(6595):421-4. PubMed ID: 3115484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of HTLV-III/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report.
    Levy N; Carlson JR; Hinrichs S; Lerche N; Schenker M; Gardner MB
    N Engl J Med; 1986 Feb; 314(7):446. PubMed ID: 3456077
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].
    Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M
    Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV and HBV infection in drug abusers in Glasgow.
    Follett EA; Wallace LA; McCruden EA
    Lancet; 1987 Apr; 1(8538):920. PubMed ID: 2882317
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevalence of markers of infection with hepatitis B, delta and HTLV-III viruses in the mentally retarded].
    Buti M; Esteban R; Sanjosé R; Jardi R; Genescá J; de Buen ML; Guardia J
    Rev Clin Esp; 1986 Sep; 179(4):175-7. PubMed ID: 3764004
    [No Abstract]   [Full Text] [Related]  

  • 16. Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts.
    Lazzarin A; Crocchiolo P; Galli M; Uberti Foppa C; Caredda F; Re T; Moroni M
    Boll Ist Sieroter Milan; 1987; 66(1):9-13. PubMed ID: 3304347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-III antibody in East Africa.
    N Engl J Med; 1986 Jul; 315(4):259-60. PubMed ID: 3014335
    [No Abstract]   [Full Text] [Related]  

  • 18. AIDS: a challenge for the public health.
    Acheson ED
    Lancet; 1986 Mar; 1(8482):662-6. PubMed ID: 2869356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-III antibody positivity in Zambian copper belt.
    Buchanan DJ; Downing RG; Tedder RS
    Lancet; 1986 Jan; 1(8473):155. PubMed ID: 2867369
    [No Abstract]   [Full Text] [Related]  

  • 20. HTLV-III infection in the RSA.
    Becker WB
    S Afr Med J; 1986 Oct; Suppl():26-7. PubMed ID: 3535115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.